{"altmetric_id":6287701,"counts":{"readers":{"mendeley":204,"citeulike":2,"connotea":0},"total":{"posts_count":5},"news":{"unique_users_count":1,"unique_users":["the_body"],"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nap"],"posts_count":1},"twitter":{"unique_users_count":2,"unique_users":["tedhouk","bob_calder"],"posts_count":2},"googleplus":{"unique_users_count":1,"unique_users":["Ted Houk"],"posts_count":1}},"selected_quotes":["15k folks, 5y, rosuvastatin 20mg v placebo gave 55% cut in vascular events, CRP less than 2 mg\/L a 62% reduction"],"citation":{"altmetric_jid":"4f6fa6393cf058f610008b2a","authors":["Ridker PM","Danielson E","Fonseca FA","Genest J","Gotto AM Jr","Kastelein JJ","Koenig W","Libby P","Lorenzatti AJ","Macfadyen JG","Nordestgaard BG","Shepherd J","Willerson JT","Glynn RJ","Paul M Ridker","Eleanor Danielson","Francisco AH Fonseca","Jacques Genest","Antonio M Gotto","John JP Kastelein","Wolfgang Koenig","Peter Libby","Alberto J Lorenzatti","Jean G MacFadyen","B\u00f8rge G Nordestgaard","James Shepherd","James T Willerson","Robert J Glynn"],"doi":"10.1016\/s0140-6736(09)60447-5","endpage":"1182","first_seen_on":"2016-03-23T16:36:36+00:00","issns":["0140-6736","01406736"],"issue":"9670","journal":"The Lancet","last_mentioned_on":1498326076,"links":["http:\/\/dx.doi.org\/10.1016\/S0140-6736(09)60447-5","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19329177","http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673609604475"],"pmid":"19329177","pubdate":"2009-04-03T23:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1175","subjects":["medicine"],"title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673609604475","volume":"373","mendeley_url":"http:\/\/www.mendeley.com\/research\/reduction-creactive-protein-ldl-cholesterol-cardiovascular-event-rates-after-initiation-rosuvastatin"},"altmetric_score":{"score":14.5,"score_history":{"1y":11.5,"6m":11.5,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":14.5},"context_for_score":{"all":{"total_number_of_other_articles":8418826,"mean":7.0849522326371,"rank":604137,"this_scored_higher_than_pct":92,"this_scored_higher_than":7812533,"rank_type":"exact","sample_size":8418826,"percentile":92},"similar_age_3m":{"total_number_of_other_articles":282950,"mean":11.283469883265,"rank":29739,"this_scored_higher_than_pct":89,"this_scored_higher_than":253118,"rank_type":"exact","sample_size":282950,"percentile":89},"this_journal":{"total_number_of_other_articles":24558,"mean":27.727480066783,"rank":6359,"this_scored_higher_than_pct":74,"this_scored_higher_than":18184,"rank_type":"exact","sample_size":24558,"percentile":74},"similar_age_this_journal_3m":{"total_number_of_other_articles":545,"mean":69.755198529412,"rank":256,"this_scored_higher_than_pct":53,"this_scored_higher_than":289,"rank_type":"exact","sample_size":545,"percentile":53}}},"demographics":{"poster_types":{"member_of_the_public":1,"researcher":1},"users":{"twitter":{"cohorts":{"Scientists":1,"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":4,"Professor > Associate Professor":18,"Librarian":3,"Researcher":52,"Student  > Doctoral Student":7,"Student  > Ph. D. Student":37,"Student  > Postgraduate":14,"Other":24,"Student  > Master":16,"Student  > Bachelor":12,"Lecturer":1,"Lecturer > Senior Lecturer":1,"Professor":14},"by_discipline":{"Medicine and Dentistry":126,"Social Sciences":1,"Psychology":1,"Unspecified":18,"Environmental Science":2,"Pharmacology, Toxicology and Pharmaceutical Science":2,"Engineering":4,"Chemistry":1,"Economics, Econometrics and Finance":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":37,"Computer Science":1,"Business, Management and Accounting":3,"Biochemistry, Genetics and Molecular Biology":5}}},"geo":{"twitter":{"US":1},"mendeley":{"HK":1,"US":9,"JP":3,"GB":1,"ES":3,"NZ":2,"GR":1,"CA":1,"NL":1,"FI":1,"BR":1,"DE":1,"ID":1}}},"posts":{"policy":[{"title":"Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease","url":"https:\/\/www.nap.edu\/download\/12869","license":"public","citation_ids":[15018954,15018958,15007802,8745956,15018965,14982114,14503455,14501536,5769396,15018976,15018978,15018981,4905371,15018988,15018990,15018994,15018996,15018999,15019005,15018532,15018534,15018535,3281296,15018537,15018539,1514569,20476850,15018544,15018545,15018546,15018548,15018549,15018550,16681814,15018552,14503461,15018553,5311896,173536,15018558,18255177,18297028,400166,15018560,4625568,233748,15018561,5411408,15018563,15018564,15018566,18255179,3622608,3292063,1390450,20476851,20476852,15007805,20476853,3293351,15018845,1033858,3571673,15018849,5101150,15018857,15018861,15018864,2013470,15018877,1275150,412858,15018883,15018885,15018887,15018893,3248370,15018897,15018903,5728586,15018916,2432020,15018925,5754876,15018936,15018941,15018945,1090744,15019407,2018914,2204740,14717287,15018946,1945902,5753418,15018951,1317679,15019009,1373013,15019010,1179290,15019015,15019019,15019023,832318,15019027,20476854,15019029,14480901,15019032,15019037,5758269,15019041,15019043,15019045,2184257,15019052,15019056,15019059,15019061,15019063,13660982,15019070,15019072,15019074,15019076,1205564,15019081,15019085,15015264,119633,15019089,14717289,15019092,1821832,15019096,187716,15019104,988508,9556682,2238045,15019106,15019108,229176,15019116,620700,2591731,11781145,15019129,16663588,15019135,15015284,15015295,20476857,1517942,20476860,1155162,3254255,15019142,15019146,216381,1487335,3096223,15019156,3173462,15019161,15019167,15019172,15019178,2951527,5467439,5467418,1765316,15019198,2666531,14503475,15019204,15019214,2581184,1410444,464117,15019218,15019223,124489,2976405,15015321,15019225,15019230,15019235,5467460,20476861,1908782,15019246,15019253,845320,4784757,15019266,1376430,2472481,15019274,15019280,908793,15019282,15019289,15019294,15019298,15019302,15019307,15015346,15019309,173736,1739091,1331925,15019318,1950318,20476864,2800499,15019327,1284216,14717032,15019333,1319616,15019340,15019342,14501604,14503456,2414671,3234146,2746118,1821831,15019349,14480506,15019353,15019360,1385577,15019366,135335,15019371,489688,15019373,15019375,16681811,14980155,5771249,205076,15019383,15018607,15019384,1368833,4428492,1445292,15019392,18267189,3397598,15019399,15019402,16681812,4749578,15019415,5731145,5747524,15019419,15019423,14503460,15019427,16681813,15019430,15018568,20471763,15018569,15018571,15018573,15018574,15018577,15018580,15018581,15018588,4504090,15018591,15018592,15018593,15018594,15018595,15018596,15018599,18255185,15048902,15015110,173852,2271426,14483900,1868667,14717282,15018610,2404961,2404967,15018615,15018616,2785224,1370976,14586818,15018625,193044,15015193,702525,15018632,228923,15018634,185134,3131915,15018640,15018645,15018651,15018657,15018663,15018670,15018674,214464,15018683,15018686,173728,15018690,15018696,15018701,14722175,15018705,15018709,18255187,20476867,2385301,15018718,941085,706696,15018725,15018729,10950651,15018737,15015230,15018741,4325138,15018746,1201563,18255190,524541,1520252,15018755,15018760,15018764,15018767,2183716,599419,15018777,5999878,5787177,20476747,15018781,15018784,2564010,1786339,15018787,589135,170812,6090867,20476869,15018790,780392,464366,176009,3173495,20476870,6287701,6287342,15018813,2111640,20476871,15018818,15018821,15018826,9090899,15018839,141079,15018842,15019432,2173331,15019436,15019440,20476872,15019447,15019450,15019453,15019458,522009,15019463,15019465,15019471,16681815,15007799,15019474,3219476,3624415,15019478,4949700,14503464,1112815,3063750,5111093,3340087,128105,1556998,5758959,15019492,2397392,1386880,15019498,15019500,15019504,15019509,15019514,15019517,15019521,4428491,14501688,3079585,1578180,2787610,15019535,410578,3281267,14598164,231647,15019537,15019544,15019548,738488,3051806,15019559,127900,3281265,3281265,3281265],"posted_on":"2010-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/12869\/evaluation-of-biomarkers-and-surrogate-endpoints-in-chronic-disease","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-c022bb1411967a7c229e99766c6431de5be4ea8a6b419543dd634fdf1adbd446.jpg"}}],"news":[{"title":"Low Vitamin D Decreases Impact of Statins in People With HIV","url":"http:\/\/ct.moreover.com\/?a=30136800977&p=1pl&v=1&x=0njyCtzjY4OJ_1xpU9G0GQ","license":"public","citation_ids":[6287701,15255950,18536665,8132534],"posted_on":"2017-04-05T20:33:52+00:00","summary":"Low 25-hydroxyvitamin D [25(OH)D] concentrations when participants entered the SATURN-HIV trial of rosuvastatin diminished the impact of the statin on low-density lipoprotein cholesterol (LDL-C) and common carotid artery intima media thickness (cIMT\u2026","author":{"name":"The Body","url":"http:\/\/www.thebody.com\/index.html?ic=3002","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/002\/532\/normal\/Screen_Shot_2016-10-26_at_09.58.02.png?1477472339"}}],"twitter":[{"url":"http:\/\/twitter.com\/tedhouk\/statuses\/878634558853402624","license":"gnip","citation_ids":[6287701],"posted_on":"2017-06-24T15:22:57+00:00","author":{"name":"Theodore C Houk, M.D","url":"http:\/\/www.healingtheworld.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1550505999\/IMG_1005_normal.JPG","description":"Runner piper healer dad of 4 Classical cynic.  Scientist by birth. Unreasonably happy.  http:\/\/towson.patch.com\/articles\/the-unusual-commute-of-dr-ted-houk","id_on_source":"tedhouk","tweeter_id":"376368318","geo":{"lt":39.00039,"ln":-76.74997,"country":"US"},"followers":86},"tweet_id":"878634558853402624"},{"url":"http:\/\/twitter.com\/bob_calder\/statuses\/878669366560260098","license":"gnip","citation_ids":[6287701],"posted_on":"2017-06-24T17:41:16+00:00","author":{"name":"Bob Calder","image":"https:\/\/pbs.twimg.com\/profile_images\/668555520517783557\/OCD9SEzS_normal.jpg","id_on_source":"bob_calder","tweeter_id":"20017902","geo":{"lt":null,"ln":null},"followers":698},"tweet_id":"878669366560260098"}],"googleplus":[{"title":"15k folks, 5y, rosuvastatin 20mg v placebo gave 55% cut in vascular events, CRP less than 2 mg\/L a 62...","url":"https:\/\/plus.google.com\/+TedHouk\/posts\/WY4eaubuQ7H","license":"public","citation_ids":[6287701],"posted_on":"2017-06-24T15:23:34+00:00","summary":"15k folks, 5y, rosuvastatin 20mg v placebo gave 55% cut in vascular events, CRP less than 2 mg\/L a 62... 15k folks, 5y, rosuvastatin 20mg v placebo gave 55% cut in vascular events, CRP less than 2 mg\/L a 62% reduction http:\/\/www.sciencedirect.com\/science\/a"}]}}